Home » Health » Cuba’s Center for Genetic Engineering and Biotechnology: Pioneering Science and Life-Saving Innovations

Cuba’s Center for Genetic Engineering and Biotechnology: Pioneering Science and Life-Saving Innovations

Image: Latin Press.

Havana, Jul 1 (RHC) – The Prime Minister of Cuba, Manuel Marrero, recognized this Saturday the work and contributions to science of the Center for Genetic Engineering and Biotechnology, on the occasion of celebrating the 37th anniversary of its creation.

Through his account on the social network Twitter, the head of government sent congratulations to the work group of the Center for Genetic Engineering and Biotechnology -CIGB-, founded on the initiative of the historic leader of the Cuban Revolution, Fidel Castro.

«You are the pride of our science. With its products, many human lives have been saved in Cuba and other parts of the world,” Marrero said on the social network.

The CIGB prints its name in the scientific history of the island and the world for the development of various drugs and vaccines such as two of the five Cuban immunogens against COVID-19: Mambisa and Abdala.

Abdala, the first vaccine conceived in Latin America, demonstrated 92.28 percent efficacy in its phase III clinical trial and millions of doses have already been administered in the Caribbean nation and in others such as Venezuela, Nicaragua, the Sahrawi Arab Democratic Republic and Vietnam. .

Data from the center itself indicate that some 40 million doses of the Abdala vaccine were delivered to the Cuban Health System for mass vaccination against COVID-19.

Mambisa, for its part, is placed among the immunogens designed globally to be administered nasally and thus attack the main entry of the SARS-CoV-2 coronavirus, which causes the COVID-19 pandemic.

Leading scientific products in our country have been in charge of the Center, such as the vaccine against hepatitis B, the epidermal growth factor, the Heberpenta vaccine and the preparation of streptokinase, obtained for the first time in the world.

It also has to its credit one of the most internationally recognized medicines: Heberprot-P, a unique and exclusive drug, designed to treat diabetic foot ulcers and reduces the risk of amputation. (Fuente: Latin Press).

2023-07-01 14:32:04
#work #Center #Genetic #Engineering #recognized #Cuba

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.